Your browser doesn't support javascript.
loading
Five ways to improve international comparisons of cancer survival: lessons learned from ICBP SURVMARK-2.
Andersson, Therese M-L; Myklebust, Tor Åge; Rutherford, Mark J; Møller, Bjørn; Arnold, Melina; Soerjomataram, Isabelle; Bray, Freddie; Parkin, D Maxwell; Lambert, Paul C.
  • Andersson TM; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. therese.m-l.andersson@ki.se.
  • Myklebust TÅ; Cancer Registry of Norway, Oslo, Norway.
  • Rutherford MJ; Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway.
  • Møller B; Biostatistics Research Group, Department of Health Sciences, University of Leicester, Leicester, UK.
  • Arnold M; Cancer Surveillance Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Soerjomataram I; Cancer Registry of Norway, Oslo, Norway.
  • Bray F; Cancer Surveillance Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Parkin DM; Cancer Surveillance Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Lambert PC; Cancer Surveillance Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Br J Cancer ; 126(8): 1224-1228, 2022 05.
Article en En | MEDLINE | ID: mdl-35058590

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Benchmarking / Neoplasias Tipo de estudio: Guideline / Incidence_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Benchmarking / Neoplasias Tipo de estudio: Guideline / Incidence_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article